ArticleDermatologic therapy2020
The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.
Article in Dermatologic therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
44 citing papers in PubMed, 3 syntheses or guidelines pooled it, 76 citations in OpenAlex.
- Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: Old players on the new field.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023Pooled it
- Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: A systematic review.Immunity, inflammation and disease · 2023Pooled it
- Kawasaki-like disease in children with COVID-19.Rheumatology international · 2020Pooled it
- Severe herpes simplex virus - 1 Kaposi varicelliform eruption and SARS-CoV-2 infection in atopic dermatitis treated with dupilumab.BMC infectious diseases · 2024Article
- COVID-19 Complications: Oxidative Stress, Inflammation, and Mitochondrial and Endothelial Dysfunction.International journal of molecular sciences · 2023Review
- Emerging evidence of microbial infection in causing systematic immune vasculitis in Kawasaki disease.Frontiers in microbiology · 2023Review
- Reader comments.Proceedings (Baylor University. Medical Center) · 2023Article
- Pityriasis rosea during COVID-19 and its pathogenesis.JAAD international · 2022Article
- Membranous desquamation of the hand in a 7-year-old boy with mild COVID-19.Clinical case reports · 2022Article
- Pityriasis rosea during the COVID-19 pandemic: Further support for a viral etiology.JAAD international · 2022Article
- Reply to "Pityriasis rosea during COVID-19 and its pathogenesis".JAAD international · 2022Article
- Coronavirus disease 2019 and pityriasis rosea: A review of the immunological connection.The Journal of dermatology · 2022Review
- Paucity of cutaneous manifestations of COVID-19 among inpatients at a referral hospital in India.JAAD international · 2022Article
- Real-world evidence from over one million COVID-19 vaccinations is consistent with reactivation of the varicella-zoster virus.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022Article
- The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review.Dermatopathology (Basel, Switzerland) · 2022Review
- Impact of COVID-19 on Clinicopathological Spectrum of Pityriasis Rosea in Korea.Journal of Korean medical science · 2022Article
- Presence and clinical impact of human herpesvirus-6 infection in patients with moderate to critical coronavirus disease-19.Journal of medical virology · 2022Article
- Experience with Cutaneous Manifestations in COVID-19 Patients during the Pandemic.Journal of clinical medicine · 2022Article
- Comment on "Pityriasis rosea in a COVID-19 Pediatric Patient".Actas dermo-sifiliograficas · 2022Article
- Impacts of COVID-19 Pandemic on Dermatology Outpatient Department at a Tertiary Hospital in Eastern China: A Pre-Post Study.Clinical, cosmetic and investigational dermatology · 2022Article
Corrections and comments
- Commented on by
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A new type of coronavirus family (SARS-CoV-2), which can be found in humans and animals, with many varieties and clinical symptoms, was first seen in Wuhan, China in late 2019, under the name novel Coronavirus Disease 2019 (COVID-19). In the literature, cutaneous symptoms related to the disease are generally emphasized. However, it is not yet known whether this new SARS-CoV-2 virus, which has entered our lives, plays a role in the etiopathogenesis of dermatological diseases. The patients who were admitted to the dermatology outpatient clinic between 1 April and 15 May 2019, and on 1 April and 15 May 2020 were retrospectively analyzed by searching the hospital automation system and patient files. The reason for the same months to be included in the study was to exclude seasonal effects on the diseases. After pandemic, the number of patients with Pityriasis rosea and Kawasaki disease increased significantly in patients who applied to the dermatology outpatient clinic. Our study is the first study showing Pityriasis rosea increase during the pandemic period. We think that this increase is related to HHV-6 reactivation. Herein, we wanted to draw attention to two diseases in which Human Herpes 6 (HHV-6) was accused in etiopathogenesis: Kawasaki disease and Pityriasis rosea.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.